SCHEMBL6606979

SCHEMBL6606979

CCCCC(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.79
SMN1; SMN2 Q16637 3/20 0.79
HPGD P15428 2/20 0.79
MAPT P10636 3/20 0.67
HSD17B3 P37058 7/20 0.65
LMNA P02545 2/20 0.65
FFAR1 O14842 1/20 0.65
CYP1A2 P05177 1/20 0.65
RAB9A P51151 1/20 0.65
HIF1A Q16665 1/20 0.65
HTR7 P34969 1/20 0.62
HDAC1 Q13547 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
KDM4E B2RXH2 2/20 0.57
ALDH1A1 P00352 2/20 0.57
AGTR1 P30556 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
POLB P06746 1/20 0.56
PTPN1 P18031 1/20 0.56
GSK3B P49841 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4453789 0.95 L3MBTL1 (0.77) L3MBTL1SMN1; SMN2HPGDMAPTHSD17B3
SCHEMBL9229529 0.93 L3MBTL1 (0.74) L3MBTL1SMN1; SMN2HPGDMAPTHSD17B3
SCHEMBL10282853 0.93 L3MBTL1 (0.74) L3MBTL1SMN1; SMN2HPGDMAPTHSD17B3
SCHEMBL13670588 0.93 L3MBTL1 (0.74) L3MBTL1SMN1; SMN2HPGDMAPTHSD17B3
SCHEMBL11661975 0.92 HSD17B3 (0.74) L3MBTL1SMN1; SMN2HPGDMAPTHSD17B3
SCHEMBL3733726 0.89 SMN1; SMN2 (1.00) L3MBTL1SMN1; SMN2HPGDMAPTHSD17B3
Valerophenone SCHEMBL5615151 0.88 L3MBTL1 (0.72) L3MBTL1SMN1; SMN2HPGDMAPTHSD17B3
Valerophenone SCHEMBL50014 0.88 L3MBTL1 (0.72) L3MBTL1SMN1; SMN2HPGDMAPTHSD17B3
Valerophenone SCHEMBL9725402 0.88 L3MBTL1 (0.72) L3MBTL1SMN1; SMN2HPGDMAPTHSD17B3
SCHEMBL28252799 0.87 L3MBTL1 (0.61) L3MBTL1SMN1; SMN2HPGDMAPTHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112358380-B Synthesis method of 4- (4' -alkylcyclohexyl) cyclohexanol 惠泽化学科技(濮阳)有限公司 2023-03-31 CN disclosed
CN-112358380-A Synthesis method of 4- (4' -alkylcyclohexyl) cyclohexanol 惠泽化学科技(濮阳)有限公司 2021-02-12 CN disclosed
EP-1142887-B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE DAVIS & CO (US) 2004-04-07 EP disclosed
EP-0729463-B1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2002-05-22 EP disclosed
EP-1142887-A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE, DAVIS & COMPANY (US) 2001-10-10 EP disclosed
US-5936128-A BENZENETHIOL COMPOUNDS AS INTERMEDIATES; BACTERICIDES, VIRICIDES; HIV WARNER-LAMBERT COMPANY (US) 1999-08-10 US disclosed
US-5840751-A ADMINISTERING IN THE TREATMENT OF INFECTION OR DISEASE CAUSED BY A RETROVIRUS WARNER-LAMBERT COMPANY (US) 1998-11-24 US disclosed
US-5789440-A 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents WARNER-LAMBERT COMPANY (US) 1998-08-04 US disclosed
EP-0729463-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729464-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014012-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014011-A2 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
US-4424371-A LIQUID CRYSTALS TIMEX CORPORATION (US) 1984-01-03 US disclosed
US-4386007-A ELECTROOPTIC DISPLAY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-05-31 US disclosed
US-4017416-A P-cyanophenyl 4-alkyl-4'-biphenylcarboxylate, method for preparing same and liquid crystal compositions using same CHISSO CORPORATION (JA) 1977-04-12 US disclosed